Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ImmunoDual: ASV and DCV in Chronic HCV
NCT02282709Phase 3Completed
- Sponsor
- Foundation for Liver Research
- Start
- Feb 2014
- Primary completion
- Jul 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of asunaprevir, daclatasvir in hepatitis C (HCV), sponsored by Foundation for Liver Research. Started Feb 2014; status: completed.
02
Drugs
asunaprevirdaclatasvir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT02282709.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02282709.